Company profile
Medicine Man Technologies, Inc.
OTC: SHWZ · Healthcare · Drug Manufacturers - Specialty & Generic
#300 of 1,422 Healthcare companies by revenue53rd-percentile growth
EA Score
——FH —DQ 52GM —SS 43
v0.1 · 25/100 weight · pillars only
↑ 3-yr revenue growth, workforce scale · ↓ market scale, growth stability
Methodology →Revenue TTM
$174.9M
Rev growth YoY (TTM)
+5.5%
Net income (FY)
-$34.5M
Employees
729
as of 2026-07-12
Market cap
$802
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$172.4M$172.4M2023
Net income-$34.5M-$34.5M2023
Operating income$3.3M$3.3M2023
Total assets$358.1M$358.1M2023
Liabilities$238.9M$238.9M2023
Equity$119.3M$119.3M2023
Revenue trend
FY2016 – FY2023 · USD
FY16
FY17
FY18
FY19
FY21
FY21
FY22
FY23
Revenue by segment
Filed disclosures · FY2023
By product
Retail90%
Wholesale10%
Other0%
By geography
Wholesale100%
The read
What is Medicine Man Technologies, Inc.’s revenue?
Medicine Man Technologies, Inc. booked $172.4M in FY2023 revenue, growing 8.2% year over year — about the middle of the pack among Healthcare companies we track, at a -20.0% net margin.
Peers · Healthcare
Stoke Therapeutics, Inc.60CHeartflow, Inc. Common Stock44DPhathom Pharmaceuticals, Inc.47DSyndax Pharmaceuticals, Inc.52DREGENXBIO Inc.54DGinkgo Bioworks Holdings, Inc.44DNeighbors
Denver →Key facts
CEOForrest Hoffmaster
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersDenver, CO
ExchangeOTC: SHWZ
Employees729
IPO date2018-02-16
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.